News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,991 Results
Type
Article (62431)
Company Profile (77)
Press Release (604473)
Multimedia
Podcasts (102)
Webinars (21)
Section
Business (174129)
Career Advice (2753)
Deals (32530)
Drug Delivery (116)
Drug Development (77193)
Employer Resources (154)
FDA (15164)
Job Trends (13950)
News (305988)
Policy (29140)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2913)
Academic (2)
Accelerated approval (35)
Adcomms (28)
Allergies (143)
Alliances (43270)
ALS (168)
Alzheimer's disease (1608)
Antibody-drug conjugate (ADC) (295)
Approvals (15442)
Artificial intelligence (536)
Autoimmune disease (167)
Automation (40)
Bankruptcy (291)
Best Places to Work (10854)
BIOSECURE Act (16)
Biosimilars (179)
Biotechnology (55)
Bladder cancer (156)
Brain cancer (61)
Breast cancer (629)
Cancer (4746)
Cardiovascular disease (398)
Career advice (2350)
Career pathing (40)
CAR-T (289)
CDC (48)
Celiac Disease (2)
Cell therapy (770)
Cervical cancer (35)
Clinical research (66144)
Collaboration (1663)
Company closure (5)
Compensation (725)
Complete response letters (59)
COVID-19 (2687)
CRISPR (97)
C-suite (923)
Cystic fibrosis (144)
Data (6180)
Decentralized trials (2)
Denatured (41)
Depression (137)
Diabetes (475)
Diagnostics (6489)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (250)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (214)
Earnings (63383)
Editorial (59)
Employer branding (18)
Employer resources (138)
Events (98794)
Executive appointments (1041)
FDA (18299)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1471)
Gene editing (205)
Generative AI (46)
Gene therapy (575)
GLP-1 (910)
Government (4717)
Grass and pollen (7)
Guidances (381)
Healthcare (18266)
HIV (60)
Huntington's disease (40)
IgA nephropathy (80)
Immunology and inflammation (226)
Immuno-oncology (55)
Indications (111)
Infectious disease (2950)
Inflammatory bowel disease (192)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (251)
Interviews (532)
IPO (14913)
IRA (45)
Job creations (3420)
Job search strategy (1948)
JPM (62)
Kidney cancer (17)
Labor market (76)
Layoffs (592)
Leadership (37)
Legal (6473)
Liver cancer (84)
Longevity (13)
Lung cancer (630)
Lymphoma (366)
Machine learning (40)
Management (54)
Manufacturing (754)
MASH (164)
Medical device (13042)
Medtech (13094)
Mergers & acquisitions (18738)
Metabolic disorders (1213)
Multiple sclerosis (154)
NASH (13)
Neurodegenerative disease (308)
Neuropsychiatric disorders (86)
Neuroscience (2813)
Neurotech (1)
NextGen: Class of 2026 (6383)
Non-profit (4353)
Now hiring (21)
Obesity (552)
Opinion (295)
Ovarian cancer (162)
Pain (201)
Pancreatic cancer (228)
Parkinson's disease (276)
Partnered (33)
Patents (507)
Patient recruitment (514)
Peanut (58)
People (61269)
Pharmaceutical (19)
Pharmacy benefit managers (26)
Phase 1 (20862)
Phase 2 (29161)
Phase 3 (21269)
Pipeline (5257)
Policy (275)
Postmarket research (2473)
Preclinical (8863)
Press Release (67)
Prostate cancer (244)
Psychedelics (42)
Radiopharmaceuticals (281)
Rare diseases (832)
Real estate (6035)
Recruiting (66)
Regulatory (22344)
Reports (41)
Research institute (2468)
Resumes & cover letters (409)
Rett syndrome (28)
RNA editing (15)
RSV (69)
Schizophrenia (144)
Series A (242)
Series B (185)
Service/supplier (8)
Sickle cell disease (95)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3380)
State (1)
Stomach cancer (12)
Supply chain (87)
Tariffs (67)
The Weekly (59)
Vaccines (980)
Venture capital (78)
Weight loss (338)
Women's health (84)
Worklife (21)
Date
Today (125)
Last 7 days (521)
Last 30 days (2226)
Last 365 days (28421)
2026 (3737)
2025 (28687)
2024 (32277)
2023 (36338)
2022 (46628)
2021 (51580)
2020 (50731)
2019 (44774)
2018 (34055)
2017 (30711)
2016 (30063)
2015 (35455)
2014 (28393)
2013 (24957)
2012 (26216)
2011 (26460)
2010 (24934)
Location
Africa (886)
Alabama (85)
Alaska (6)
Arizona (239)
Arkansas (14)
Asia (39411)
Australia (7072)
California (10418)
Canada (3099)
China (1057)
Colorado (441)
Connecticut (447)
Delaware (330)
Europe (91912)
Florida (1574)
Georgia (349)
Hawaii (3)
Idaho (59)
Illinois (878)
India (67)
Indiana (480)
Iowa (22)
Japan (416)
Kansas (119)
Kentucky (39)
Louisiana (26)
Maine (75)
Maryland (1282)
Massachusetts (7344)
Michigan (335)
Minnesota (564)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (26)
Nevada (113)
New Hampshire (77)
New Jersey (2895)
New Mexico (30)
New York (2844)
North Carolina (1417)
North Dakota (10)
Northern California (5028)
Ohio (322)
Oklahoma (23)
Oregon (42)
Pennsylvania (2059)
Puerto Rico (24)
Rhode Island (45)
South America (1187)
South Carolina (53)
South Dakota (1)
Southern California (4148)
Tennessee (170)
Texas (1667)
United States (37405)
Utah (324)
Vermont (1)
Virginia (259)
Washington D.C. (66)
Washington State (859)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
666,991 Results for "university of calgary".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
October 10, 2025
·
5 min read
Drug Development
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
Arch Biopartners Inc. announced today that the University of Calgary’s Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
June 18, 2024
·
5 min read
Business
University of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from the University of Calgary’s Cumming School of Medicine has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
March 15, 2024
·
5 min read
Press Releases
Biosenta’s Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens at Industry-Low Dose in Peer-Reviewed Studies
Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles
June 11, 2025
·
5 min read
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary announce largest donation in Alberta Health Service’s history to the new Calgary Cancer Centre
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary are thrilled to announce a historic and transformational $50 million donation to the Calgary Cancer Centre from the Arthur J.E. Child Foundation.
June 28, 2023
·
7 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Press Releases
Charles River Enters Manufacturing Collaboration with Gazi University
January 21, 2026
·
2 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
·
6 min read
1 of 66,700
Next
